Email Updates

Search form

You are here

Multipurpose Prevention Technologies

HIV prevention and women’s reproductive health go hand in hand.

HIV prevention doesn’t happen in isolation. Even when people are at high risk for HIV, avoiding infection is but one factor in a complex set of decisions about their health and well-being. For women worldwide, those decisions include childbearing and reproductive and sexual health.

Multi-purpose prevention technologies are now in development to simultaneously prevent unintended pregnancy and protect against HIV and other sexually transmitted infections. By addressing multiple health concerns in convenient, easy-to-use formulations, these technologies might also help ensure high levels of product adherence. Multiple versions are entering early clinical trials now. Many important questions about efficacy, acceptability and adherence need to be addressed as this research proceeds.

What We're Reading

A novel combination tenofovir/levonorgestrel ring, as well as a tenofovir-only ring, are currently in expanded clinical development.

August 1, 2018

A new Phase I study of the Population Council’s multipurpose prevention technology (MPT) gel PC-1005, launching this week, will examine the safety of the gel when used rectally by both men and women. If proven effective, PC-1005 gel would be the first product to prevent three incurable sexually transmitted infections (STIs)—HIV, herpes simplex virus (HSV), and human papillomavirus (HPV).

June 21, 2018
Population Council

Whether in the United States or Ethiopia, women needed more options to protect themselves. They needed comprehensive prevention methods they could control and use discreetly. They needed MPTs.

June 8, 2018
Ms. Blog
Subscribe to RSS - Multipurpose Prevention Technologies